Press Releases

March 27, 2023 Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules

March 25, 2023 Lupin Announces Completion of Pharmacovigilance Inspection by the U.S. FDA with No Observations

March 25, 2023 Lupin Announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities

March 23, 2023 Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets

March 21, 2023 Lupin Receives Approval from US FDA for Brexpiprazole Tablets

March 20, 2023 Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium Bromide Injection

March 20, 2023 Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Thiamine Hydrochloride Injection USP

March 17, 2023 Lupin Digital Health Unveils Results of India’s First Digital Therapeutics Study with ACS Patients

March 13, 2023 Lupin Bio research Centre Completes U.S. FDA Inspection with No Observations